ASF1B and neoplasm: We conducted a pan‐cancer analysis of ASF1B using multiple databases, including Oncomine, HPA, CCLE, and TGCA, to characterize ASF1B expression and its correlation with prognosis, immune response, clinicopathology, and tumor microenvironment in diverse cancers.